Tvardi Therapeutics, Inc. (TVRD)
1.63
+0.01
(+0.62%)
USD |
NASDAQ |
Sep 18, 16:00
1.70
+0.07
(+4.29%)
After-Hours: 04:17
Tvardi Therapeutics Market Cap : 15.29M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 15.29M |
| September 17, 2026 | 15.20M |
| September 16, 2026 | 16.23M |
| September 15, 2026 | 16.51M |
| September 14, 2026 | 17.17M |
| September 11, 2026 | 17.54M |
| September 10, 2026 | 17.21M |
| September 09, 2026 | 17.36M |
| September 08, 2026 | 18.20M |
| September 04, 2026 | 17.92M |
| September 03, 2026 | 17.36M |
| September 02, 2026 | 17.64M |
| September 01, 2026 | 16.37M |
| August 31, 2026 | 16.89M |
| August 28, 2026 | 17.07M |
| August 27, 2026 | 16.89M |
| August 26, 2026 | 16.70M |
| August 25, 2026 | 17.07M |
| August 24, 2026 | 16.70M |
| August 21, 2026 | 17.45M |
| August 20, 2026 | 17.17M |
| August 19, 2026 | 17.64M |
| August 18, 2026 | 17.82M |
| August 17, 2026 | 17.45M |
| August 14, 2026 | 17.82M |
| Date | Value |
|---|---|
| August 13, 2026 | 16.60M |
| August 12, 2026 | 16.60M |
| August 11, 2026 | 16.60M |
| August 10, 2026 | 16.51M |
| August 07, 2026 | 17.54M |
| August 06, 2026 | 17.36M |
| August 05, 2026 | 18.76M |
| August 04, 2026 | 19.04M |
| August 03, 2026 | 18.95M |
| July 31, 2026 | 19.70M |
| July 30, 2026 | 19.70M |
| July 29, 2026 | 20.08M |
| July 28, 2026 | 22.89M |
| July 27, 2026 | 23.83M |
| July 24, 2026 | 23.55M |
| July 23, 2026 | 24.02M |
| July 22, 2026 | 25.89M |
| July 21, 2026 | 26.83M |
| July 20, 2026 | 27.49M |
| July 17, 2026 | 30.02M |
| July 16, 2026 | 28.89M |
| July 15, 2026 | 27.49M |
| July 14, 2026 | 29.08M |
| July 13, 2026 | 31.05M |
| July 10, 2026 | 30.77M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.085T |
| Liquidia Corp. | 5.959B |
| ANI Pharmaceuticals, Inc. | 1.749B |
| Corcept Therapeutics, Inc. | 11.90B |
| Veru, Inc. | 41.09M |
Market Cap Related Metrics
| Price to Book Value | 1.824 |
| Price | 1.63 |
| Earnings Yield | -170.5% |